Cancer Gene Therapy: Impact Factor, Indexing, Publication Time & Fees

---

The Cancer Gene Therapy is reputed journal publishes research related to Biochemistry, Genetics and Molecular Biology. The ISSN of the journal is 14765500.

Through this web page, researchers can check the indexing, publication fee, journal quartile, and journal aim & scope.

Cancer Gene Therapy: Details

Journal Title	Cancer Gene Therapy
Publisher	Nature Publishing Group
Publication Country	CAMPUS, 4 CRINAN ST, LONDON, ENGLAND, N1 9XW
ISSN	14765500
Publication Area	Biotechnology & Applied Microbiology | Oncology | Genetics & Heredity | Medicine, Research & Experimental
Publication Language	English
Review Process
Scopus Indexed	Yes

Cancer Gene Therapy Impact Factor

The Impact Factor of Cancer Gene Therapy in 2026 is 4.8.

Journal Quartile

The Cancer Gene Therapy is ranked in Q1.

Indexing

The Cancer Gene Therapy is indexed in: Scopus, Web of Science, PubMed, Embase, UGC CARE Group 2.

Similiar journals to publish

---

Journal of RNAi and Gene Silencing : An International Journal of RNA and Gene Targeting Research

ISSN: 1747-0854
Publisher: Library Publishing Media
Journal Scope:

Cancer Gene Therapy

ISSN: 14765500
Publisher: Nature Publishing Group
Journal Scope: Biochemistry, Genetics and Molecular Biology

Gene Therapy

ISSN: 14765462
Publisher: Nature Publishing Group
Journal Scope: Biochemistry, Genetics and Molecular Biology

Human Gene Therapy

ISSN: 1557-7422
Publisher: Mary Ann Liebert, Inc.
Journal Scope: Biochemistry, Genetics and Molecular Biology

Human Gene Therapy Methods

ISSN: 1946-6544
Publisher: Mary Ann Liebert, Inc.
Journal Scope: Biochemistry, Genetics and Molecular Biology; Immunology and Microbiology; Medicine; Pharmacology, Toxicology and Pharmaceutics

Human Gene Therapy. Clinical Development

ISSN: 2324-8645
Publisher: Mary Ann Liebert, Inc.
Journal Scope: Medicine